Atara Biotherapeutics Statistics
Total Valuation
LON:0HIY has a market cap or net worth of GBP 40.76 million. The enterprise value is 61.58 million.
Market Cap | 40.76M |
Enterprise Value | 61.58M |
Important Dates
The next estimated earnings date is Thursday, August 7, 2025.
Earnings Date | Aug 7, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 5.96M |
Shares Outstanding | n/a |
Shares Change (YoY) | +90.64% |
Shares Change (QoQ) | +1.32% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 3.44M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 2.84 |
PS Ratio | 0.26 |
PB Ratio | -0.96 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.42, with an EV/FCF ratio of -1.18.
EV / Earnings | -5.09 |
EV / Sales | 0.42 |
EV / EBITDA | 4.42 |
EV / EBIT | n/a |
EV / FCF | -1.18 |
Financial Position
The company has a current ratio of 0.57
Current Ratio | 0.57 |
Quick Ratio | 0.47 |
Debt / Equity | n/a |
Debt / EBITDA | 2.23 |
Debt / FCF | -0.62 |
Interest Coverage | -0.72 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -1.77% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | -22.76% |
Revenue Per Employee | 1.74M |
Profits Per Employee | -136,022 |
Employee Count | 153 |
Asset Turnover | 1.76 |
Inventory Turnover | n/a |
Taxes
Income Tax | -27,864 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +11.16% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +11.16% |
50-Day Moving Average | 7.95 |
200-Day Moving Average | 8.85 |
Relative Strength Index (RSI) | 66.77 |
Average Volume (20 Days) | 234 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 4.93 |
Income Statement
In the last 12 months, LON:0HIY had revenue of GBP 154.59 million and -12.11 million in losses. Loss per share was -1.38.
Revenue | 154.59M |
Gross Profit | 27.53M |
Operating Income | -2.49M |
Pretax Income | -12.13M |
Net Income | -12.11M |
EBITDA | 1.73M |
EBIT | -2.49M |
Loss Per Share | -1.38 |
Balance Sheet
The company has 10.71 million in cash and 32.46 million in debt, giving a net cash position of -21.75 million.
Cash & Cash Equivalents | 10.71M |
Total Debt | 32.46M |
Net Cash | -21.75M |
Net Cash Per Share | n/a |
Equity (Book Value) | -42.63M |
Book Value Per Share | -7.20 |
Working Capital | -16.03M |
Cash Flow
In the last 12 months, operating cash flow was -52.05 million and capital expenditures -92,105, giving a free cash flow of -52.14 million.
Operating Cash Flow | -52.05M |
Capital Expenditures | -92,105 |
Free Cash Flow | -52.14M |
FCF Per Share | n/a |
Margins
Gross margin is 17.81%, with operating and profit margins of -1.61% and -7.83%.
Gross Margin | 17.81% |
Operating Margin | -1.61% |
Pretax Margin | -7.85% |
Profit Margin | -7.83% |
EBITDA Margin | 1.12% |
EBIT Margin | -1.61% |
FCF Margin | n/a |
Dividends & Yields
LON:0HIY does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -90.64% |
Shareholder Yield | n/a |
Earnings Yield | -29.70% |
FCF Yield | -127.91% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on June 20, 2024. It was a reverse split with a ratio of 0.04.
Last Split Date | Jun 20, 2024 |
Split Type | Reverse |
Split Ratio | 0.04 |
Scores
LON:0HIY has an Altman Z-Score of -42.57 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -42.57 |
Piotroski F-Score | 2 |